Biogen, Inc. (BIIB)
232.65
-2.70
(-1.15%)
USD |
NASDAQ |
Oct 16, 16:00
233.94
+1.29
(+0.55%)
After-Hours: 20:00
Biogen Cash from Investing (Quarterly) : -3.839B for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.839B |
| March 31, 2026 | -209.50M |
| December 31, 2025 | -1.232B |
| September 30, 2025 | -35.10M |
| June 30, 2025 | -57.00M |
| March 31, 2025 | -47.30M |
| December 31, 2024 | -18.60M |
| September 30, 2024 | -1.181B |
| June 30, 2024 | 466.50M |
| March 31, 2024 | -66.00M |
| December 31, 2023 | -644.20M |
| September 30, 2023 | -1.740B |
| June 30, 2023 | -752.00M |
| March 31, 2023 | -952.80M |
| December 31, 2022 | -140.90M |
| September 30, 2022 | 1.684B |
| June 30, 2022 | 693.50M |
| March 31, 2022 | -648.00M |
| December 31, 2021 | -112.70M |
| September 30, 2021 | -233.60M |
| June 30, 2021 | -152.70M |
| March 31, 2021 | -64.70M |
| December 31, 2020 | -166.40M |
| September 30, 2020 | -52.40M |
| June 30, 2020 | -832.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 442.90M |
| December 31, 2019 | 708.40M |
| September 30, 2019 | -365.90M |
| June 30, 2019 | -110.80M |
| March 31, 2019 | 238.80M |
| December 31, 2018 | -1.625B |
| September 30, 2018 | -619.10M |
| June 30, 2018 | -1.148B |
| March 31, 2018 | 1.347B |
| December 31, 2017 | -769.50M |
| September 30, 2017 | -1.247B |
| June 30, 2017 | -202.60M |
| March 31, 2017 | -744.20M |
| December 31, 2016 | -581.70M |
| September 30, 2016 | 36.20M |
| June 30, 2016 | -736.10M |
| March 31, 2016 | -1.203B |
| December 31, 2015 | -1.808B |
| September 30, 2015 | -989.94M |
| June 30, 2015 | -1.253B |
| March 31, 2015 | -502.77M |
| December 31, 2014 | -378.28M |
| September 30, 2014 | -540.56M |
| June 30, 2014 | -630.13M |
| March 31, 2014 | 5.993M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -1.197B |
| Gilead Sciences, Inc. | -10.35B |
| Amgen, Inc. | -569.00M |
| Ionis Pharmaceuticals, Inc. | 23.50M |
| Regeneron Pharmaceuticals, Inc. | -92.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 448.90M |
| Cash from Financing (Quarterly) | 1.296B |
| Free Cash Flow | 2.49B |
| Free Cash Flow Per Share (Quarterly) | 2.071 |
| Free Cash Flow to Equity (Quarterly) | -1.485B |
| Free Cash Flow to Firm (Quarterly) | 368.61M |
| Free Cash Flow Yield | 7.25% |